CIK 0001789192
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nexentis Technologies Inc.
Sign in to watch- Ticker
- NXTS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 264684680
- Phone
- +972 544561349
- Business address
- 156 FIFTH AVENUE 10TH FLOOR, CO EARTHBOUND LLC, NEW YORK, NY, 10010-7751
- Former names
- N2OFF, Inc., Save Foods, Inc., Save Foods Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-23 | Berenstein Israel Yakov Director | Grant or award | +50,000 | 64,500 | ||
| 2024-12-23 | Arbib Eliahou Director | Grant or award | +50,000 | 64,500 | ||
| 2024-12-23 | Weiss Amitay Director | Grant or award | +350,000 | 450,000 | ||
| 2024-12-23 | Itzhaik Asaf Director | Grant or award | +50,000 | 50,000 | ||
| 2024-09-12 | Barda Lital Chief Financial Officer | Grant or award | +160,000 | 202,857 | ||
| 2024-09-12 | Palach David Chief Executive Officer | Grant or award | +320,000 | 420,000 | ||
| 2023-12-20 | Weiss Amitay Director | Purchase | +100,000 | 100,000 | ||
| 2023-12-20 | Rosenbloom Ronen Director | Purchase | +14,500 | 14,500 | ||
| 2023-12-20 | Palach David Chief Executive Officer | Grant or award | +57,142 | 100,000 | ||
| 2023-12-20 | Kalifi Udi Ovadia Director | Purchase | +14,500 | 18,457 | ||
| 2023-12-20 | Berenstein Israel Yakov Director | Purchase | +14,500 | 14,500 | ||
| 2023-12-20 | Barda Lital Chief Financial Officer | Grant or award | +28,571 | 42,857 | ||
| 2023-12-20 | Arbib Eliahou Director | Purchase | +14,500 | 14,500 | ||
| 2023-03-29 | Palach David Chief Executive Officer | Grant or award | +300,000 | 300,000 | ||
| 2023-03-29 | Barda Lital Chief Financial Officer | Grant or award | +100,000 | 100,000 | ||
| 2022-06-16 | Kalifi Udi Ovadia Director | Purchase | +18,422 | $3.30 | $61K | 27,692 |
| 2022-06-15 | Kalifi Udi Ovadia Director | Purchase | +9,270 | $3.16 | $29K | 9,270 |
| 2020-09-24 | Goldwasser Benad Director | Option exercise | +68,000 | $0.30 | $20K | 400,000 |
| 2020-09-24 | Goldwasser Benad Director | Option exercise · Warrants (Right to Buy) | −68,000 | 125,000 | ||
| 2020-09-22 | Goldwasser Benad Director | Option exercise | +132,000 | $0.30 | $40K | 332,000 |
Page 2 of 3 · 42 trades